FDA inspection
GlaxoSmithKline LLC: FDA inspection ending May 10, 2006
FDA inspection 424715 · Voluntary Action Indicated (VAI) · King of Prussia, PA
Key facts
| Inspection ID | 424715 |
|---|---|
| Firm | GlaxoSmithKline LLC |
| FEI number | 1000522100 |
| Address | 709 Swedeland Rd |
| City | King of Prussia |
| State | PA |
| ZIP | 19406-2711 |
| Fiscal year | 2006 |
| Inspection end date | May 10, 2006 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | New Drug Evaluation |
| Product type | Drugs |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data